Showing results (1141-1150 of 2,231) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|April 17, 2020
MiR-524-5p Suppresses Migration, Invasion, and EMT Progression in Breast Cancer Cells Through Targeting FSTL1Taobo Jin, Yun Zhang, Tianya Zhang
Cancer Biotherapy & Radiopharmaceuticals|May 15, 2020
LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer CellsJianguang Wang, Shuaijun Dong, Jianfeng Zhang, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 16, 2020
LncRNA DDX11-AS1 Promotes Bladder Cancer Occurrence Via Protecting LAMB3 from Downregulation by Sponging miR-2355-5pDong Chen, Junyi Chen, Jialin Gao, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 16, 2020
High Expression of Asparagine Synthetase Is Associated with Poor Prognosis of Breast Cancer in Chinese PopulationChunxin Qin, Xiaoqing Yang, Zhiyong Zhan
Cancer Biotherapy & Radiopharmaceuticals|May 16, 2020
Long Noncoding RNA UCA1 Facilitates Endometrial Cancer Development by Regulating KLF5 and RXFP1 Gene ExpressionsTong Liu, Xia Wang, Jingfang Zhai, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 29, 2020
MicroRNA-215 Regulates the Apoptosis of HCT116 Colon Cancer Cells by Inhibiting X-Linked Inhibitor of Apoptosis ProteinChuanhui Lu, Ming Hong, Bo Chen, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 12, 2020
Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18AChunhui Zhou, Zhen Chen, Changli Peng, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 8, 2021
Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient PrognosisXinxin Lu, Runzhou Li, Xingshuang Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2015
γ-Glutamylcyclotransferase Knockdown Inhibits Growth of Lung Cancer Cells Through G0/G1 Phase ArrestZhifeng Lin, Liwen Xiong, Jianhua Zhou, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 23, 2020
Deletion of HNF1A-AS1 Suppresses the Malignant Phenotypes of Breast Cancer Cells In Vitro and In Vivo Through Targeting miRNA-20a-5p/TRIM32 AxisQingjie Meng, Linlin Wang, Yonggang Lv, et al.
Pageof 224